Tadaga 60mg .

What is Tadaga Super 60mg Tadalafil ??

The presented product called tadagra strong is in the form of small yellow, oval tablets with a number 60 debossed on one side of the tablet which indicates the amount of active ingredient tadalafil 60 mg contained in it.

What is Tadalafil used for?

Tadalafil is used to treat erections (also called impotence).

 In adult men, consisting in the inability to obtain or maintain an erection of the penis (erection) to a sufficient degree to achieve a satisfying sexual intercourse. The condition for the effectiveness of Tadalafil is sexual stimulation. How should I use Tadalafil? The recommended dose of Tadalafil is 60mg, taken with or without food, but its absorption is significantly longer, and empty stomachs should be used at least 30 minutes before sexual activity. The maximum recommended frequency of use is one tablet a day. Patients with impaired liver function or severe renal impairment should take a dose of not more than 10 mg per 24 h. The constant daily use of Tadalafil is strongly discouraged because its action usually lasts longer than one day, ie up to 36 hours, and the safety of long-term use after prolonged daily dosing is not known enough.


How does Tadalafil work ??

The active substance in Tadalafil belongs to the group of medicines called 'phosphodiesterase 5 (PDE5) inhibitors'. Tadalafil inhibits the phosphodiesterase enzyme, which normally breaks down a substance known as cyclic GMP (cGMP). During normal sexual stimulation, cGMP is produced in the penis, where it causes the smooth muscle of the corpora cavernosa (corpora cavernosa) to relax, allowing a greater inflow of blood to the corpora cavernosa, which induces an erection. By inhibiting the breakdown of cGMP, Tadalafil restores erectile function. Sexual stimulation is still needed.


How has Tadalafil been studied ??

Tadalafil has been studied in six main studies involving 1328 patients, compared with placebo (a dummy treatment). One study only included men with © EMEA 2006 2/2 diabetes. The determinant of effectiveness was the ability to get and maintain an erection. The information was recorded in two questionnaires filled in at home.

What benefits of Tadalafil have been shown in studies ??

In all of the studies, Tadalafil was significantly more effective than placebo. In the case of one of the questionnaires, in which the maximum number of points was 30, patients who obtained a result close to 15, after receiving Tadalafil 60mg obtained a score of 22.6 or 25 respectively. Overall, in a general population study, 80% of patients reported improvement erection after taking Tadalafil compared with 34% of patients taking placebo.

What is the risk associated with Tadalafil ??

The most common side effects (in more than 1 patient in 10) are headache and indigestion. For the full list of all side effects reported with Tadalafil, see the Package Leaflet. Tadalafil should not be used by people who are hypersensitive (allergic) to tadalafil or any of the other ingredients, and who are not advised to be sexually active (eg men with heart disease). Scifilnie should also be used by patients who have suffered loss of vision due to impaired blood flow to the nerve in the eye (NAION, or ischemic frontal optic neuropathy). The use of Tadalafil with nitrates (medicines used to treat angina) is contraindicated. The physician should consider the potential risk of disorders associated with sexual activity in men with cardiovascular disease. Tadalafil has not been studied in patients who have had a heart attack in the past 3 months or who have had a stroke or have had problems with their blood pressure or heart (irregular heartbeat) in the last 6 months. The full list of restrictions is provided in the package leaflet.

Why has Tadalafil been approved?

The Committee for Medicinal Products for Human Use (CHMP) decided that Tadalafil's benefits are greater than its risks for the treatment of men with erectile dysfunction. The Committee recommended the granting of a marketing authorization for Tadalafil. Other information about Tadalafil; On 12 November 2002, the European Commission granted Lilly ICOS Limited a marketing authorization for Tadalafil valid throughout the European Union.